(Q34074674)

30 July 2017

1 reference

title

Anti-TNF agents in Crohn's disease (English)

1 reference

30 July 2017

0 references

0 references

0 references

2

Rutgeerts P

1 reference

30 July 2017

Van Assche G

1

1 reference

PubMed ID

11060664

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

1

1 reference

30 July 2017

103-111

1 reference

Inflammatory bowel disease: etiology and pathogenesis.

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.103

21 January 2018

Identifiers

DOI

10.1517/13543784.9.1.103

1 reference

30 July 2017

1 reference

PubMed ID

11060664